News stories about Cardiovascular Systems (NASDAQ:CSII) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Cardiovascular Systems earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 46.0698500037918 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Shares of NASDAQ CSII opened at $22.87 on Friday. Cardiovascular Systems has a 1 year low of $20.58 and a 1 year high of $33.11. The firm has a market cap of $770.66, a P/E ratio of 762.33 and a beta of 2.15. The company has a current ratio of 4.65, a quick ratio of 4.13 and a debt-to-equity ratio of 0.17.
Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings results on Wednesday, February 7th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.03. Cardiovascular Systems had a negative net margin of 1.62% and a negative return on equity of 0.50%. The firm had revenue of $52.63 million for the quarter, compared to the consensus estimate of $53.39 million. During the same period in the prior year, the firm posted $0.03 earnings per share. The firm’s quarterly revenue was up 5.2% compared to the same quarter last year. research analysts anticipate that Cardiovascular Systems will post -0.07 EPS for the current year.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.